The development of a mobile molecular diagnostic device, the Akili MDx, to assist healthcare professionals with accurate diagnostics in the lab and in-field.The Akili MDx is in development and will assist in quick & early pathogen detection at a genetic level of HIV, Influenza, SARS-CoV-2 and future novel viruses. 

Intellectual Property Protection

Opportunity type

Technology Readiness Level